The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development.
Signaling mediated by various Notch receptors and their ligands regulates diverse biological processes, including lymphoid cell fate decisions. Notch1 is required during T-cell development, while Notch2 and the Notch ligand Delta-like1 control marginal zone B (MZB) cell development. We previously determined that Mastermind-like (MAML) transcriptional coactivators are required for Notchinduced transcription by forming ternary nuclear complexes with Notch and the transcription factor CSL. The 3 MAML family members (MAML1-MAML3) are collectively essential for Notch activity in vivo, but whether individual MAMLs contribute to the specificity of Notch functions is unknown. Here, we addressed this question by studying lymphopoiesis in the absence of the Maml1 gene. Since Maml1(-/-) mice suffered perinatal lethality, hematopoietic chimeras were generated with Maml1(-/-), Maml1(+/-), or wild-type fetal liver progenitors. Maml1 deficiency minimally affected T-cell development, but was required for the development of MZB cells, similar to the phenotype of Notch2 deficiency. Moreover, the number of MZB cells correlated with Maml1 gene dosage. Since all 3 Maml genes were expressed in MZB cells and their precursors, these results suggest that Maml1 is specifically required for Notch2 signaling in MZB cells.
Wu
Lizi
L
Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. lzwu@ufl.edu
Maillard
Ivan
I
Nakamura
Makoto
M
Pear
Warren S
WS
Griffin
James D
JD
D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology* / Q000502:physiology*; D002678:Chimera / Q000196:embryology; D005260:Female; D017353:Gene Deletion; D018507:Gene Expression Regulation, Developmental; D008099:Liver / Q000166:cytology / Q000196:embryology / Q000378:metabolism; D008221:Lymphoid Tissue / Q000196:embryology* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009687:Nuclear Proteins / Q000235:genetics / Q000502:physiology*; D011247:Pregnancy; D051883:Receptor, Notch2 / Q000502:physiology*; D013601:T-Lymphocytes / Q000166:cytology; D015534:Trans-Activators / Q000235:genetics / Q000502:physiology; D014157:Transcription Factors / Q000235:genetics / Q000502:physiology*
C467909:MAML2 protein, mouse; C467910:MAML3 protein, mouse; C486455:Maml1 protein, mouse; C497765:Notch2 protein, mouse; D009687:Nuclear Proteins; D051883:Receptor, Notch2; D015534:Trans-Activators; D014157:Transcription Factors
Nature. 2000 May 18;405(6784):364-8
10830967
Nature. 1999 Apr 8;398(6727):518-22
10206645
Nat Immunol. 2002 May;3(5):443-50
11967543
Nat Rev Immunol. 2002 May;2(5):323-35
12033738
Int Immunol. 2002 Jun;14(6):637-45
12039915
Genes Dev. 2002 Jun 1;16(11):1397-411
12050117
Immunity. 1999 May;10(5):547-58
10367900
Blood. 2004 Nov 15;104(10):3097-105
15251982
Annu Rev Immunol. 2005;23:945-74
15771590
Nat Immunol. 2005 Jul;6(7):663-70
15951813
Cell. 2006 Mar 10;124(5):973-83
16530044
Genes Dev. 2006 Mar 15;20(6):675-88
16510869
J Exp Med. 2006 Jun 12;203(6):1579-90
16754723
Immunity. 2006 Jul;25(1):105-16
16814577
J Exp Med. 2006 Oct 2;203(10):2239-45
16966428
Nat Immunol. 2007 May;8(5):451-6
17440450
Immunity. 2002 Jun;16(6):869-79
12121668
Mol Cell Biol. 2002 Nov;22(21):7688-700
12370315
J Biol Chem. 2002 Dec 27;277(52):50612-20
12386158
Immunity. 2003 May;18(5):675-85
12753744
Immunity. 2003 May;18(5):699-711
12753746
Nat Immunol. 2004 Mar;5(3):247-53
14985712
J Immunol. 2004 May 1;172(9):5230-9
15100261
Immunity. 2004 May;20(5):611-22
15142529
Nat Immunol. 2004 Jun;5(6):638-44
15146182
Semin Cancer Biol. 2004 Oct;14(5):348-56
15288260
J Exp Med. 2004 Aug 16;200(4):469-79
15314075
Blood. 2004 Sep 15;104(6):1696-702
15187027
Curr Biol. 1995 Dec 1;5(12):1416-23
8749394
Nat Genet. 2000 Dec;26(4):484-9
11101851